Industry Research Reports

Home > Reports > Service & Software > Microphysiological System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Microphysiological System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Service & Software

Published Date: 2026-08-27

Pages: 174 Pages

Report ld: 5513295

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Industry Insights:

Microphysiological System Research:CAGR of 19.6% during the forecast period

biaoTi KEY FINDINGS

Microphysiological System (MPS) technology is primarily applied in pharmaceutical research, biotechnology development, and biomedical studies

Organ-on-a-Chip represents the core technology platform within the Microphysiological System market

Human organ and tissue models are the major product direction for improving physiological relevance in vitro

Microfluidic-based MPS remains the mainstream technology architecture for commercial platforms

North America maintains a leading position in Microphysiological System commercialization and research activities

Microphysiological System Market Size(US$)

CAGR 2026-2032

16.2%

Market Size,2032

USD 438

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 178 million

Market Forecast in 2032(Value)

US$ 438 million

CAGR

16.2%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Microphysiological System was estimated to be worth US$ 150 million in 2025 and is projected to reach US$ 438 million, growing at a CAGR of 16.2% from 2026 to 2032.

Microphysiological System (MPS) refers to an advanced in vitro biological platform that integrates microengineering, tissue engineering, microfluidics, biomaterials, and living human cells to replicate key physiological functions, structures, and interactions of human organs and tissues. The technology enables more physiologically relevant models compared with traditional two-dimensional cell culture by recreating complex cellular environments, fluid flow conditions, and biological responses. The research scope mainly covers human organ and tissue models, disease models, and non-human species models developed through Organ-on-a-Chip, Tissue-on-a-Chip, Body-on-a-Chip, and related microphysiological technologies. These systems are primarily applied in pharmaceutical and biotechnology research, preclinical drug evaluation, toxicology testing, disease mechanism studies, and advanced biomedical research.

biaoTi MARKET TRENDS

The Microphysiological System (MPS) industry is evolving from single-organ simulation toward more complex human-relevant biological models integrating multiple tissues, organ interactions, sensors, and advanced cell sources. The combination of Organ-on-a-Chip, organoid technologies, microfluidics, and real-time monitoring capabilities is improving the accuracy of preclinical evaluation and expanding applications beyond traditional drug screening. Pharmaceutical companies are increasingly exploring MPS platforms as part of new approach methodologies for improving prediction of drug efficacy, pharmacokinetics, and toxicity responses.

MARKET SEGMENTATION

By Company

Emulate
Mimetas
TissUse
InSphero
CN Bio
Hesperos
28bio
Beijing Daxiang Biotech
Nortis (Quris-Al)
NETRI
Bi/ond
AlveoliX
BiomimX
React4Life
SynVivo
Ananda Devices
Dynamic42
BEOnChip
Altis Biosystems
Newcells Biotech
ImmuONE
TNO
Valo Health (TARA Biosystems)
Draper Laboratory
Cherry Biotech
Obatala Sciences
Aracari Bio
StemPharm
AVATARGET
Suzhou Jiyan Biopharmaceutical

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Human Organ and Tissue Models
Disease Models
Non-Human Species Models

Segment by Application

Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Others

Segment by Category

Organ-on-a-Chip
Tissue-on-a-Chip
Body-on-a-Chip
Others

Segment by Division

Microfluidic-based MPS
3D Bioprinting-based MPS
Scaffold-based Tissue Engineering MPS
Sensor-integrated MPS

biaoTi MARKET DYNAMICS

Drivers

The primary drivers of Microphysiological System (MPS) adoption include increasing demand for human-relevant preclinical models, continued investment in pharmaceutical innovation, and the need to improve drug development efficiency. Growing interest in reducing reliance on traditional animal testing approaches is accelerating the adoption of organ-on-chip and other human-cell-based platforms in pharmaceutical research and toxicology evaluation.

Restraints

Market expansion is limited by challenges including high technology complexity, lack of standardized manufacturing processes, difficulties in large-scale production, and the need for further validation of MPS models across different biological applications. Integration of biological components, microfluidic systems, and analytical technologies also increases development costs and technical requirements.

Opportunities

Future opportunities are emerging from personalized medicine, patient-derived models, advanced disease modeling, and integration with artificial intelligence and automated screening platforms. Multi-organ systems, organoid-based MPS, and sensor-integrated platforms are expected to expand the application scope of Microphysiological System technologies in pharmaceutical discovery and precision healthcare.

Challenges

The industry faces challenges related to regulatory acceptance, reproducibility between laboratories, standardization of testing protocols, and commercialization scalability. Although MPS technologies demonstrate strong potential for improving biological prediction, broader adoption requires consistent performance validation and integration into established drug development workflows.

biaoTi INDUSTRY CHAIN ANALYSIS

The Microphysiological System industry chain includes upstream suppliers of biological materials, microfluidic chips, biomaterials, sensors, cell culture components, and manufacturing equipment. Midstream companies develop MPS platforms by integrating microfluidic engineering, tissue engineering, cell biology, and analytical technologies. Downstream users mainly include pharmaceutical companies, biotechnology companies, academic and research institutes, and other biomedical organizations. The primary value creation process focuses on improving physiological relevance, reducing experimental uncertainty, and providing more predictive models for drug development and biological research.

biaoTi SEGMENT INSIGHTS

By type, Microphysiological System includes Human Organ and Tissue Models, Disease Models, and Non-Human Species Models. Human Organ and Tissue Models represent the primary commercial direction due to their relevance in pharmaceutical testing and human biology simulation. By technology platform, Organ-on-a-Chip, Tissue-on-a-Chip, and Body-on-a-Chip represent the major development pathways, with multi-organ systems providing opportunities for more comprehensive biological modeling. By technology architecture, Microfluidic-based MPS remains the dominant platform, while 3D Bioprinting-based MPS, Scaffold-based Tissue Engineering MPS, and Sensor-integrated MPS provide additional technological opportunities.

biaoTi DOWNSTREAM MARKET OPPORTUNITIES

The largest downstream opportunity for Microphysiological System (MPS) is pharmaceutical and biotechnology research, where companies utilize these platforms for drug discovery, efficacy evaluation, toxicity assessment, and preclinical validation. Academic and research institutions represent another important application segment, supporting disease mechanism studies and technology development. Emerging opportunities are also developing in personalized medicine, precision therapeutics, and patient-specific biological modeling.

biaoTi REGIONAL INSIGHTS

North America represents one of the most developed regions for Microphysiological System commercialization due to strong pharmaceutical research capabilities, biotechnology innovation, and early adoption of advanced biomedical technologies. Europe also maintains significant activity supported by life science research and alternative testing technology development. Asia-Pacific is becoming an important growth region driven by expanding pharmaceutical industries, biotechnology investment, and increasing research capabilities in countries such as China and Japan.

Fastest-Growing Region: Asia Pacific

XX.X
%
CAGR*
XXXX
US$ Million
XXXX
REGIONAL SHARE

BY TYPE,2021-2032(US $ MILLION)

Human Organ and Tissue Models

Disease Models

Non-Human Species Models

BY APPLICATION，2021-2032(US $ MILLION）

Pharmaceutical & Biotechnology Companies

Academic & Research Institutes

Others

biaoTi COMPETITIVE LANDSCAPE ANALYSIS

The Microphysiological System market is characterized by specialized technology companies, biotechnology firms, research institutions, and platform developers focusing on different biological models and application scenarios. Competition mainly centers on model physiological relevance, platform scalability, integration capability, application validation, and compatibility with pharmaceutical workflows. Companies developing Organ-on-a-Chip, multi-organ systems, organoid-based models, and automated testing platforms are strengthening their positions as MPS moves from research-oriented applications toward broader commercial adoption.

biaoTi REPORT SCOPE

This report provides a comprehensive view of the global market for Microphysiological System, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Microphysiological System market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Microphysiological System.

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.

Chapter 2: Provides a detailed analysis of the Microphysiological System companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).

Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 5: Presents Microphysiological System revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.

Chapter 6: Presents Microphysiological System revenue at the country level. It provides segmented data by Type and by Application for each country/region.

Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.

Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Microphysiological System Product Introduction

1.2 Global Microphysiological System Market Size Forecast (2021–2032)

1.3 Microphysiological System Market Trends & Drivers

1.3.1 Microphysiological System Industry Trends

1.3.2 Microphysiological System Market Drivers & Opportunities

1.3.3 Microphysiological System Market Challenges

1.3.4 Microphysiological System Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Microphysiological System Players Revenue Ranking (2025)

2.2 Global Microphysiological System Revenue by Company (2021–2026)

2.3 Key Companies’ R&D and Operations Footprint and Headquarters

2.4 Key Companies Microphysiological System Product Offerings

2.5 Key Companies General Availability (GA) Timeline for Microphysiological System

2.6 Microphysiological System Market Competitive Analysis

2.6.1 Microphysiological System Market Concentration Rate (2021–2026)

2.6.2 Top 5 and Top 10 Global Companies by Microphysiological System Revenue in 2025

2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Microphysiological System revenue, 2025

2.7 Mergers & Acquisitions and Expansion

3 Segmentation Microphysiological System Market Classification

3.1 Introduction by Type

3.1.1 Human Organ and Tissue Models

3.1.2 Disease Models

3.1.3 Non-Human Species Models

3.1.4 Global Microphysiological System Sales Value by Type

3.1.4.1 Global Microphysiological System Sales Value by Type (2021 vs 2025 vs 2032)

3.1.4.2 Global Microphysiological System Sales Value, by Type (2021–2032)

3.1.4.3 Global Microphysiological System Sales Value, by Type (%), 2021–2032

3.2 Introduction by Technology Platform

3.2.1 Organ-on-a-Chip

3.2.2 Tissue-on-a-Chip

3.2.3 Body-on-a-Chip

3.2.4 Others

3.2.5 Global Microphysiological System Sales Value by Technology Platform

3.2.5.1 Global Microphysiological System Sales Value by Technology Platform (2021 vs 2025 vs 2032)

3.2.5.2 Global Microphysiological System Sales Value, by Technology Platform (2021–2032)

3.2.5.3 Global Microphysiological System Sales Value, by Technology Platform (%), 2021–2032

3.3 Introduction by Technology Architecture

3.3.1 Microfluidic-based MPS

3.3.2 3D Bioprinting-based MPS

3.3.3 Scaffold-based Tissue Engineering MPS

3.3.4 Sensor-integrated MPS

3.3.5 Global Microphysiological System Sales Value by Technology Architecture

3.3.5.1 Global Microphysiological System Sales Value by Technology Architecture (2021 vs 2025 vs 2032)

3.3.5.2 Global Microphysiological System Sales Value, by Technology Architecture (2021–2032)

3.3.5.3 Global Microphysiological System Sales Value, by Technology Architecture (%), 2021–2032

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Pharmaceutical & Biotechnology Companies

4.1.2 Academic & Research Institutes

4.1.3 Others

4.2 Global Microphysiological System Sales Value by Application

4.2.1 Global Microphysiological System Sales Value by Application (2021 vs 2025 vs 2032)

4.2.2 Global Microphysiological System Sales Value by Application (2021–2032)

4.2.3 Global Microphysiological System Sales Value by Application (%), 2021–2032

5 Segmentation by Region

5.1 Global Microphysiological System Sales Value by Region

5.1.1 Global Microphysiological System Sales Value by Region: 2021 vs 2025 vs 2032

5.1.2 Global Microphysiological System Sales Value by Region (2021–2026)

5.1.3 Global Microphysiological System Sales Value by Region (2027–2032)

5.1.4 Global Microphysiological System Sales Value by Region (%), 2021–2032

5.2 North America

5.2.1 North America Microphysiological System Sales Value, 2021–2032

5.2.2 North America Microphysiological System Sales Value by Country (%), 2025 vs 2032

5.3 Europe

5.3.1 Europe Microphysiological System Sales Value, 2021–2032

5.3.2 Europe Microphysiological System Sales Value by Country (%), 2025 vs 2032

5.4 Asia Pacific

5.4.1 Asia Pacific Microphysiological System Sales Value, 2021–2032

5.4.2 Asia Pacific Microphysiological System Sales Value by Subregion (%), 2025 vs 2032

5.5 South America

5.5.1 South America Microphysiological System Sales Value, 2021–2032

5.5.2 South America Microphysiological System Sales Value by Country (%), 2025 vs 2032

5.6 Middle East & Africa

5.6.1 Middle East & Africa Microphysiological System Sales Value, 2021–2032

5.6.2 Middle East & Africa Microphysiological System Sales Value by Country (%), 2025 vs 2032

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Microphysiological System Sales Value Growth Trends, 2021 vs 2025 vs 2032

6.2 Key Countries/Regions Microphysiological System Sales Value, 2021–2032

6.3 United States

6.3.1 United States Microphysiological System Sales Value, 2021–2032

6.3.2 United States Microphysiological System Sales Value by Type (%), 2025 vs 2032

6.3.3 United States Microphysiological System Sales Value by Application, 2025 vs 2032

6.4 Europe

6.4.1 Europe Microphysiological System Sales Value, 2021–2032

6.4.2 Europe Microphysiological System Sales Value by Type (%), 2025 vs 2032

6.4.3 Europe Microphysiological System Sales Value by Application, 2025 vs 2032

6.5 China

6.5.1 China Microphysiological System Sales Value, 2021–2032

6.5.2 China Microphysiological System Sales Value by Type (%), 2025 vs 2032

6.5.3 China Microphysiological System Sales Value by Application, 2025 vs 2032

6.6 Japan

6.6.1 Japan Microphysiological System Sales Value, 2021–2032

6.6.2 Japan Microphysiological System Sales Value by Type (%), 2025 vs 2032

6.6.3 Japan Microphysiological System Sales Value by Application, 2025 vs 2032

6.7 South Korea

6.7.1 South Korea Microphysiological System Sales Value, 2021–2032

6.7.2 South Korea Microphysiological System Sales Value by Type (%), 2025 vs 2032

6.7.3 South Korea Microphysiological System Sales Value by Application, 2025 vs 2032

6.8 Southeast Asia

6.8.1 Southeast Asia Microphysiological System Sales Value, 2021–2032

6.8.2 Southeast Asia Microphysiological System Sales Value by Type (%), 2025 vs 2032

6.8.3 Southeast Asia Microphysiological System Sales Value by Application, 2025 vs 2032

6.9 India

6.9.1 India Microphysiological System Sales Value, 2021–2032

6.9.2 India Microphysiological System Sales Value by Type (%), 2025 vs 2032

6.9.3 India Microphysiological System Sales Value by Application, 2025 vs 2032

7 Company Profiles

7.1 Emulate

7.1.1 Emulate Profile

7.1.2 Emulate Main Business

7.1.3 Emulate Microphysiological System Products, Services, and Solutions

7.1.4 Emulate Microphysiological System Revenue (US$ Million), 2021–2026

7.1.5 Emulate Recent Developments

7.2 Mimetas

7.2.1 Mimetas Profile

7.2.2 Mimetas Main Business

7.2.3 Mimetas Microphysiological System Products, Services, and Solutions

7.2.4 Mimetas Microphysiological System Revenue (US$ Million), 2021–2026

7.2.5 Mimetas Recent Developments

7.3 TissUse

7.3.1 TissUse Profile

7.3.2 TissUse Main Business

7.3.3 TissUse Microphysiological System Products, Services, and Solutions

7.3.4 TissUse Microphysiological System Revenue (US$ Million), 2021–2026

7.3.5 TissUse Recent Developments

7.4 InSphero

7.4.1 InSphero Profile

7.4.2 InSphero Main Business

7.4.3 InSphero Microphysiological System Products, Services, and Solutions

7.4.4 InSphero Microphysiological System Revenue (US$ Million), 2021–2026

7.4.5 InSphero Recent Developments

7.5 CN Bio

7.5.1 CN Bio Profile

7.5.2 CN Bio Main Business

7.5.3 CN Bio Microphysiological System Products, Services, and Solutions

7.5.4 CN Bio Microphysiological System Revenue (US$ Million), 2021–2026

7.5.5 CN Bio Recent Developments

7.6 Hesperos

7.6.1 Hesperos Profile

7.6.2 Hesperos Main Business

7.6.3 Hesperos Microphysiological System Products, Services, and Solutions

7.6.4 Hesperos Microphysiological System Revenue (US$ Million), 2021–2026

7.6.5 Hesperos Recent Developments

7.7 28bio

7.7.1 28bio Profile

7.7.2 28bio Main Business

7.7.3 28bio Microphysiological System Products, Services, and Solutions

7.7.4 28bio Microphysiological System Revenue (US$ Million), 2021–2026

7.7.5 28bio Recent Developments

7.8 Beijing Daxiang Biotech

7.8.1 Beijing Daxiang Biotech Profile

7.8.2 Beijing Daxiang Biotech Main Business

7.8.3 Beijing Daxiang Biotech Microphysiological System Products, Services, and Solutions

7.8.4 Beijing Daxiang Biotech Microphysiological System Revenue (US$ Million), 2021–2026

7.8.5 Beijing Daxiang Biotech Recent Developments

7.9 Nortis (Quris-Al)

7.9.1 Nortis (Quris-Al) Profile

7.9.2 Nortis (Quris-Al) Main Business

7.9.3 Nortis (Quris-Al) Microphysiological System Products, Services, and Solutions

7.9.4 Nortis (Quris-Al) Microphysiological System Revenue (US$ Million), 2021–2026

7.9.5 Nortis (Quris-Al) Recent Developments

7.10 NETRI

7.10.1 NETRI Profile

7.10.2 NETRI Main Business

7.10.3 NETRI Microphysiological System Products, Services, and Solutions

7.10.4 NETRI Microphysiological System Revenue (US$ Million), 2021–2026

7.10.5 NETRI Recent Developments

7.11 Bi/ond

7.11.1 Bi/ond Profile

7.11.2 Bi/ond Main Business

7.11.3 Bi/ond Microphysiological System Products, Services, and Solutions

7.11.4 Bi/ond Microphysiological System Revenue (US$ Million), 2021–2026

7.11.5 Bi/ond Recent Developments

7.12 AlveoliX

7.12.1 AlveoliX Profile

7.12.2 AlveoliX Main Business

7.12.3 AlveoliX Microphysiological System Products, Services, and Solutions

7.12.4 AlveoliX Microphysiological System Revenue (US$ Million), 2021–2026

7.12.5 AlveoliX Recent Developments

7.13 BiomimX

7.13.1 BiomimX Profile

7.13.2 BiomimX Main Business

7.13.3 BiomimX Microphysiological System Products, Services, and Solutions

7.13.4 BiomimX Microphysiological System Revenue (US$ Million), 2021–2026

7.13.5 BiomimX Recent Developments

7.14 React4Life

7.14.1 React4Life Profile

7.14.2 React4Life Main Business

7.14.3 React4Life Microphysiological System Products, Services, and Solutions

7.14.4 React4Life Microphysiological System Revenue (US$ Million), 2021–2026

7.14.5 React4Life Recent Developments

7.15 SynVivo

7.15.1 SynVivo Profile

7.15.2 SynVivo Main Business

7.15.3 SynVivo Microphysiological System Products, Services, and Solutions

7.15.4 SynVivo Microphysiological System Revenue (US$ Million), 2021–2026

7.15.5 SynVivo Recent Developments

7.16 Ananda Devices

7.16.1 Ananda Devices Profile

7.16.2 Ananda Devices Main Business

7.16.3 Ananda Devices Microphysiological System Products, Services, and Solutions

7.16.4 Ananda Devices Microphysiological System Revenue (US$ Million), 2021–2026

7.16.5 Ananda Devices Recent Developments

7.17 Dynamic42

7.17.1 Dynamic42 Profile

7.17.2 Dynamic42 Main Business

7.17.3 Dynamic42 Microphysiological System Products, Services, and Solutions

7.17.4 Dynamic42 Microphysiological System Revenue (US$ Million), 2021–2026

7.17.5 Dynamic42 Recent Developments

7.18 BEOnChip

7.18.1 BEOnChip Profile

7.18.2 BEOnChip Main Business

7.18.3 BEOnChip Microphysiological System Products, Services, and Solutions

7.18.4 BEOnChip Microphysiological System Revenue (US$ Million), 2021–2026

7.18.5 BEOnChip Recent Developments

7.19 Altis Biosystems

7.19.1 Altis Biosystems Profile

7.19.2 Altis Biosystems Main Business

7.19.3 Altis Biosystems Microphysiological System Products, Services, and Solutions

7.19.4 Altis Biosystems Microphysiological System Revenue (US$ Million), 2021–2026

7.19.5 Altis Biosystems Recent Developments

7.20 Newcells Biotech

7.20.1 Newcells Biotech Profile

7.20.2 Newcells Biotech Main Business

7.20.3 Newcells Biotech Microphysiological System Products, Services, and Solutions

7.20.4 Newcells Biotech Microphysiological System Revenue (US$ Million), 2021–2026

7.20.5 Newcells Biotech Recent Developments

7.21 ImmuONE

7.21.1 ImmuONE Profile

7.21.2 ImmuONE Main Business

7.21.3 ImmuONE Microphysiological System Products, Services, and Solutions

7.21.4 ImmuONE Microphysiological System Revenue (US$ Million), 2021–2026

7.21.5 ImmuONE Recent Developments

7.22 TNO

7.22.1 TNO Profile

7.22.2 TNO Main Business

7.22.3 TNO Microphysiological System Products, Services, and Solutions

7.22.4 TNO Microphysiological System Revenue (US$ Million), 2021–2026

7.22.5 TNO Recent Developments

7.23 Valo Health (TARA Biosystems)

7.23.1 Valo Health (TARA Biosystems) Profile

7.23.2 Valo Health (TARA Biosystems) Main Business

7.23.3 Valo Health (TARA Biosystems) Microphysiological System Products, Services, and Solutions

7.23.4 Valo Health (TARA Biosystems) Microphysiological System Revenue (US$ Million), 2021–2026

7.23.5 Valo Health (TARA Biosystems) Recent Developments

7.24 Draper Laboratory

7.24.1 Draper Laboratory Profile

7.24.2 Draper Laboratory Main Business

7.24.3 Draper Laboratory Microphysiological System Products, Services, and Solutions

7.24.4 Draper Laboratory Microphysiological System Revenue (US$ Million), 2021–2026

7.24.5 Draper Laboratory Recent Developments

7.25 Cherry Biotech

7.25.1 Cherry Biotech Profile

7.25.2 Cherry Biotech Main Business

7.25.3 Cherry Biotech Microphysiological System Products, Services, and Solutions

7.25.4 Cherry Biotech Microphysiological System Revenue (US$ Million), 2021–2026

7.25.5 Cherry Biotech Recent Developments

7.26 Obatala Sciences

7.26.1 Obatala Sciences Profile

7.26.2 Obatala Sciences Main Business

7.26.3 Obatala Sciences Microphysiological System Products, Services, and Solutions

7.26.4 Obatala Sciences Microphysiological System Revenue (US$ Million), 2021–2026

7.26.5 Obatala Sciences Recent Developments

7.27 Aracari Bio

7.27.1 Aracari Bio Profile

7.27.2 Aracari Bio Main Business

7.27.3 Aracari Bio Microphysiological System Products, Services, and Solutions

7.27.4 Aracari Bio Microphysiological System Revenue (US$ Million), 2021–2026

7.27.5 Aracari Bio Recent Developments

7.28 StemPharm

7.28.1 StemPharm Profile

7.28.2 StemPharm Main Business

7.28.3 StemPharm Microphysiological System Products, Services, and Solutions

7.28.4 StemPharm Microphysiological System Revenue (US$ Million), 2021–2026

7.28.5 StemPharm Recent Developments

7.29 AVATARGET

7.29.1 AVATARGET Profile

7.29.2 AVATARGET Main Business

7.29.3 AVATARGET Microphysiological System Products, Services, and Solutions

7.29.4 AVATARGET Microphysiological System Revenue (US$ Million), 2021–2026

7.29.5 AVATARGET Recent Developments

7.30 Suzhou Jiyan Biopharmaceutical

7.30.1 Suzhou Jiyan Biopharmaceutical Profile

7.30.2 Suzhou Jiyan Biopharmaceutical Main Business

7.30.3 Suzhou Jiyan Biopharmaceutical Microphysiological System Products, Services, and Solutions

7.30.4 Suzhou Jiyan Biopharmaceutical Microphysiological System Revenue (US$ Million), 2021–2026

7.30.5 Suzhou Jiyan Biopharmaceutical Recent Developments

8 Industry Chain Analysis

8.1 Microphysiological System Value Chain

8.2 Microphysiological System Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Key Suppliers of Raw Materials

8.2.3 Cost Structure

8.3 Midstream Analysis

8.4 Downstream (Customer) Analysis

8.5 Sales Model and Sales Channelss

8.5.1 Microphysiological System Sales Model

8.5.2 Sales Channels

8.5.3 Microphysiological System Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Microphysiological System Market Trends

Table 2. Microphysiological System Market Drivers & Opportunities

Table 3. Microphysiological System Market Challenges

Table 4. Microphysiological System Market Restraints

Table 5. Global Microphysiological System Revenue by Company (US$ Million), 2021–2026

Table 6. Global Microphysiological System Revenue Market Share by Company (2021–2026)

Table 7. Key Companies’ R&D and Operations Footprint and Headquarters

Table 8. Key Companies Microphysiological System Product Type

Table 9. Key Companies General Availability (GA) Timeline for Microphysiological System

Table 10. Global Microphysiological System Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Microphysiological System revenue, 2025

Table 12. Mergers & Acquisitions and Expansion Plans

Table 13. Global Microphysiological System Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)

Table 14. Global Microphysiological System Sales Value by Type (US$ Million), 2021–2026

Table 15. Global Microphysiological System Sales Value by Type (US$ Million), 2027–2032

Table 16. Global Microphysiological System Sales Market Share in Value by Type (2021–2026)

Table 17. Global Microphysiological System Sales Market Share in Value by Type (2027–2032)

Table 18. Global Microphysiological System Sales Value by Technology Platform: 2021 vs 2025 vs 2032 (US$ Million)

Table 19. Global Microphysiological System Sales Value by Technology Platform (US$ Million), 2021–2026

Table 20. Global Microphysiological System Sales Value by Technology Platform (US$ Million), 2027–2032

Table 21. Global Microphysiological System Sales Market Share in Value by Technology Platform (2021–2026)

Table 22. Global Microphysiological System Sales Market Share in Value by Technology Platform (2027–2032)

Table 23. Global Microphysiological System Sales Value by Technology Architecture: 2021 vs 2025 vs 2032 (US$ Million)

Table 24. Global Microphysiological System Sales Value by Technology Architecture (US$ Million), 2021–2026

Table 25. Global Microphysiological System Sales Value by Technology Architecture (US$ Million), 2027–2032

Table 26. Global Microphysiological System Sales Market Share in Value by Technology Architecture (2021–2026)

Table 27. Global Microphysiological System Sales Market Share in Value by Technology Architecture (2027–2032)

Table 28. Global Microphysiological System Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)

Table 29. Global Microphysiological System Sales Value by Application (US$ Million), 2021–2026

Table 30. Global Microphysiological System Sales Value by Application (US$ Million), 2027–2032

Table 31. Global Microphysiological System Sales Market Share in Value by Application (2021–2026)

Table 32. Global Microphysiological System Sales Market Share in Value by Application (2027–2032)

Table 33. Global Microphysiological System Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032

Table 34. Global Microphysiological System Sales Value by Region (US$ Million), 2021–2026

Table 35. Global Microphysiological System Sales Value by Region (US$ Million), 2027–2032

Table 36. Global Microphysiological System Sales Value by Region (%), 2021–2026

Table 37. Global Microphysiological System Sales Value by Region (%), 2027–2032

Table 38. Key Countries/Regions Microphysiological System Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032

Table 39. Key Countries/Regions Microphysiological System Sales Value, (US$ Million), 2021–2026

Table 40. Key Countries/Regions Microphysiological System Sales Value, (US$ Million), 2027–2032

Table 41. Emulate Basic Information List

Table 42. Emulate Description and Business Overview

Table 43. Emulate Microphysiological System Products, Services, and Solutions

Table 44. Revenue (US$ Million) in Microphysiological System Business of Emulate (2021–2026)

Table 45. Emulate Recent Developments

Table 46. Mimetas Basic Information List

Table 47. Mimetas Description and Business Overview

Table 48. Mimetas Microphysiological System Products, Services, and Solutions

Table 49. Revenue (US$ Million) in Microphysiological System Business of Mimetas (2021–2026)

Table 50. Mimetas Recent Developments

Table 51. TissUse Basic Information List

Table 52. TissUse Description and Business Overview

Table 53. TissUse Microphysiological System Products, Services, and Solutions

Table 54. Revenue (US$ Million) in Microphysiological System Business of TissUse (2021–2026)

Table 55. TissUse Recent Developments

Table 56. InSphero Basic Information List

Table 57. InSphero Description and Business Overview

Table 58. InSphero Microphysiological System Products, Services, and Solutions

Table 59. Revenue (US$ Million) in Microphysiological System Business of InSphero (2021–2026)

Table 60. InSphero Recent Developments

Table 61. CN Bio Basic Information List

Table 62. CN Bio Description and Business Overview

Table 63. CN Bio Microphysiological System Products, Services, and Solutions

Table 64. Revenue (US$ Million) in Microphysiological System Business of CN Bio (2021–2026)

Table 65. CN Bio Recent Developments

Table 66. Hesperos Basic Information List

Table 67. Hesperos Description and Business Overview

Table 68. Hesperos Microphysiological System Products, Services, and Solutions

Table 69. Revenue (US$ Million) in Microphysiological System Business of Hesperos (2021–2026)

Table 70. Hesperos Recent Developments

Table 71. 28bio Basic Information List

Table 72. 28bio Description and Business Overview

Table 73. 28bio Microphysiological System Products, Services, and Solutions

Table 74. Revenue (US$ Million) in Microphysiological System Business of 28bio (2021–2026)

Table 75. 28bio Recent Developments

Table 76. Beijing Daxiang Biotech Basic Information List

Table 77. Beijing Daxiang Biotech Description and Business Overview

Table 78. Beijing Daxiang Biotech Microphysiological System Products, Services, and Solutions

Table 79. Revenue (US$ Million) in Microphysiological System Business of Beijing Daxiang Biotech (2021–2026)

Table 80. Beijing Daxiang Biotech Recent Developments

Table 81. Nortis (Quris-Al) Basic Information List

Table 82. Nortis (Quris-Al) Description and Business Overview

Table 83. Nortis (Quris-Al) Microphysiological System Products, Services, and Solutions

Table 84. Revenue (US$ Million) in Microphysiological System Business of Nortis (Quris-Al) (2021–2026)

Table 85. Nortis (Quris-Al) Recent Developments

Table 86. NETRI Basic Information List

Table 87. NETRI Description and Business Overview

Table 88. NETRI Microphysiological System Products, Services, and Solutions

Table 89. Revenue (US$ Million) in Microphysiological System Business of NETRI (2021–2026)

Table 90. NETRI Recent Developments

Table 91. Bi/ond Basic Information List

Table 92. Bi/ond Description and Business Overview

Table 93. Bi/ond Microphysiological System Products, Services, and Solutions

Table 94. Revenue (US$ Million) in Microphysiological System Business of Bi/ond (2021–2026)

Table 95. Bi/ond Recent Developments

Table 96. AlveoliX Basic Information List

Table 97. AlveoliX Description and Business Overview

Table 98. AlveoliX Microphysiological System Products, Services, and Solutions

Table 99. Revenue (US$ Million) in Microphysiological System Business of AlveoliX (2021–2026)

Table 100. AlveoliX Recent Developments

Table 101. BiomimX Basic Information List

Table 102. BiomimX Description and Business Overview

Table 103. BiomimX Microphysiological System Products, Services, and Solutions

Table 104. Revenue (US$ Million) in Microphysiological System Business of BiomimX (2021–2026)

Table 105. BiomimX Recent Developments

Table 106. React4Life Basic Information List

Table 107. React4Life Description and Business Overview

Table 108. React4Life Microphysiological System Products, Services, and Solutions

Table 109. Revenue (US$ Million) in Microphysiological System Business of React4Life (2021–2026)

Table 110. React4Life Recent Developments

Table 111. SynVivo Basic Information List

Table 112. SynVivo Description and Business Overview

Table 113. SynVivo Microphysiological System Products, Services, and Solutions

Table 114. Revenue (US$ Million) in Microphysiological System Business of SynVivo (2021–2026)

Table 115. SynVivo Recent Developments

Table 116. Ananda Devices Basic Information List

Table 117. Ananda Devices Description and Business Overview

Table 118. Ananda Devices Microphysiological System Products, Services, and Solutions

Table 119. Revenue (US$ Million) in Microphysiological System Business of Ananda Devices (2021–2026)

Table 120. Ananda Devices Recent Developments

Table 121. Dynamic42 Basic Information List

Table 122. Dynamic42 Description and Business Overview

Table 123. Dynamic42 Microphysiological System Products, Services, and Solutions

Table 124. Revenue (US$ Million) in Microphysiological System Business of Dynamic42 (2021–2026)

Table 125. Dynamic42 Recent Developments

Table 126. BEOnChip Basic Information List

Table 127. BEOnChip Description and Business Overview

Table 128. BEOnChip Microphysiological System Products, Services, and Solutions

Table 129. Revenue (US$ Million) in Microphysiological System Business of BEOnChip (2021–2026)

Table 130. BEOnChip Recent Developments

Table 131. Altis Biosystems Basic Information List

Table 132. Altis Biosystems Description and Business Overview

Table 133. Altis Biosystems Microphysiological System Products, Services, and Solutions

Table 134. Revenue (US$ Million) in Microphysiological System Business of Altis Biosystems (2021–2026)

Table 135. Altis Biosystems Recent Developments

Table 136. Newcells Biotech Basic Information List

Table 137. Newcells Biotech Description and Business Overview

Table 138. Newcells Biotech Microphysiological System Products, Services, and Solutions

Table 139. Revenue (US$ Million) in Microphysiological System Business of Newcells Biotech (2021–2026)

Table 140. Newcells Biotech Recent Developments

Table 141. ImmuONE Basic Information List

Table 142. ImmuONE Description and Business Overview

Table 143. ImmuONE Microphysiological System Products, Services, and Solutions

Table 144. Revenue (US$ Million) in Microphysiological System Business of ImmuONE (2021–2026)

Table 145. ImmuONE Recent Developments

Table 146. TNO Basic Information List

Table 147. TNO Description and Business Overview

Table 148. TNO Microphysiological System Products, Services, and Solutions

Table 149. Revenue (US$ Million) in Microphysiological System Business of TNO (2021–2026)

Table 150. TNO Recent Developments

Table 151. Valo Health (TARA Biosystems) Basic Information List

Table 152. Valo Health (TARA Biosystems) Description and Business Overview

Table 153. Valo Health (TARA Biosystems) Microphysiological System Products, Services, and Solutions

Table 154. Revenue (US$ Million) in Microphysiological System Business of Valo Health (TARA Biosystems) (2021–2026)

Table 155. Valo Health (TARA Biosystems) Recent Developments

Table 156. Draper Laboratory Basic Information List

Table 157. Draper Laboratory Description and Business Overview

Table 158. Draper Laboratory Microphysiological System Products, Services, and Solutions

Table 159. Revenue (US$ Million) in Microphysiological System Business of Draper Laboratory (2021–2026)

Table 160. Draper Laboratory Recent Developments

Table 161. Cherry Biotech Basic Information List

Table 162. Cherry Biotech Description and Business Overview

Table 163. Cherry Biotech Microphysiological System Products, Services, and Solutions

Table 164. Revenue (US$ Million) in Microphysiological System Business of Cherry Biotech (2021–2026)

Table 165. Cherry Biotech Recent Developments

Table 166. Obatala Sciences Basic Information List

Table 167. Obatala Sciences Description and Business Overview

Table 168. Obatala Sciences Microphysiological System Products, Services, and Solutions

Table 169. Revenue (US$ Million) in Microphysiological System Business of Obatala Sciences (2021–2026)

Table 170. Obatala Sciences Recent Developments

Table 171. Aracari Bio Basic Information List

Table 172. Aracari Bio Description and Business Overview

Table 173. Aracari Bio Microphysiological System Products, Services, and Solutions

Table 174. Revenue (US$ Million) in Microphysiological System Business of Aracari Bio (2021–2026)

Table 175. Aracari Bio Recent Developments

Table 176. StemPharm Basic Information List

Table 177. StemPharm Description and Business Overview

Table 178. StemPharm Microphysiological System Products, Services, and Solutions

Table 179. Revenue (US$ Million) in Microphysiological System Business of StemPharm (2021–2026)

Table 180. StemPharm Recent Developments

Table 181. AVATARGET Basic Information List

Table 182. AVATARGET Description and Business Overview

Table 183. AVATARGET Microphysiological System Products, Services, and Solutions

Table 184. Revenue (US$ Million) in Microphysiological System Business of AVATARGET (2021–2026)

Table 185. AVATARGET Recent Developments

Table 186. Suzhou Jiyan Biopharmaceutical Basic Information List

Table 187. Suzhou Jiyan Biopharmaceutical Description and Business Overview

Table 188. Suzhou Jiyan Biopharmaceutical Microphysiological System Products, Services, and Solutions

Table 189. Revenue (US$ Million) in Microphysiological System Business of Suzhou Jiyan Biopharmaceutical (2021–2026)

Table 190. Suzhou Jiyan Biopharmaceutical Recent Developments

Table 191. Revenue (US$ Million) in Microphysiological System Business of Company 40 (2021–2026)

Table 192. Company 40 Recent Developments

Table 193. Key Raw Materials Lists

Table 194. Key Suppliers of Raw Materials Lists

Table 195. Microphysiological System Downstream Customers

Table 196. Microphysiological System Distributors List

Table 197. Research Programs/Design for This Report

Table 198. Key Data Information from Secondary Sources

Table 199. Key Data Information from Primary Sources

List of Figures

Figure 1. Microphysiological System Product Picture

Figure 2. Global Microphysiological System Sales Value, 2021 vs 2025 vs 2032 (US$ Million)

Figure 3. Global Microphysiological System Sales Value (US$ Million), 2021–2032

Figure 4. Microphysiological System Report Years Considered

Figure 5. Global Microphysiological System Players Revenue Ranking (US$ Million), 2025

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Microphysiological System Revenue in 2025

Figure 7. Microphysiological System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 8. Human Organ and Tissue Models Picture

Figure 9. Disease Models Picture

Figure 10. Non-Human Species Models Picture

Figure 11. Global Microphysiological System Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032

Figure 12. Global Microphysiological System Sales Value Market Share by Type, 2025 & 2032

Figure 13. Organ-on-a-Chip Picture

Figure 14. Tissue-on-a-Chip Picture

Figure 15. Body-on-a-Chip Picture

Figure 16. Others Picture

Figure 17. Global Microphysiological System Sales Value by Technology Platform (US$ Million), 2021 vs 2025 vs 2032

Figure 18. Global Microphysiological System Sales Value Market Share by Technology Platform, 2025 & 2032

Figure 19. Microfluidic-based MPS Picture

Figure 20. 3D Bioprinting-based MPS Picture

Figure 21. Scaffold-based Tissue Engineering MPS Picture

Figure 22. Sensor-integrated MPS Picture

Figure 23. Global Microphysiological System Sales Value by Technology Architecture (US$ Million), 2021 vs 2025 vs 2032

Figure 24. Global Microphysiological System Sales Value Market Share by Technology Architecture, 2025 & 2032

Figure 25. Product Picture of Pharmaceutical & Biotechnology Companies

Figure 26. Product Picture of Academic & Research Institutes

Figure 27. Product Picture of Others

Figure 28. Global Microphysiological System Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032

Figure 29. Global Microphysiological System Sales Value Market Share by Application, 2025 & 2032

Figure 30. North America Microphysiological System Sales Value (US$ Million), 2021–2032

Figure 31. North America Microphysiological System Sales Value by Country (%), 2025 vs 2032

Figure 32. Europe Microphysiological System Sales Value (US$ Million), 2021–2032

Figure 33. Europe Microphysiological System Sales Value by Country (%), 2025 vs 2032

Figure 34. Asia Pacific Microphysiological System Sales Value (US$ Million), 2021–2032

Figure 35. Asia Pacific Microphysiological System Sales Value by Subregion (%), 2025 vs 2032

Figure 36. South America Microphysiological System Sales Value (US$ Million), 2021–2032

Figure 37. South America Microphysiological System Sales Value by Country (%), 2025 vs 2032

Figure 38. Middle East & Africa Microphysiological System Sales Value (US$ Million), 2021–2032

Figure 39. Middle East & Africa Microphysiological System Sales Value by Country (%), 2025 vs 2032

Figure 40. Key Countries/Regions Microphysiological System Sales Value (%), 2021–2032

Figure 41. United States Microphysiological System Sales Value (US$ Million), 2021–2032

Figure 42. United States Microphysiological System Sales Value by Type (%), 2025 vs 2032

Figure 43. United States Microphysiological System Sales Value by Application (%), 2025 vs 2032

Figure 44. Europe Microphysiological System Sales Value (US$ Million), 2021–2032

Figure 45. Europe Microphysiological System Sales Value by Type (%), 2025 vs 2032

Figure 46. Europe Microphysiological System Sales Value by Application (%), 2025 vs 2032

Figure 47. China Microphysiological System Sales Value (US$ Million), 2021–2032

Figure 48. China Microphysiological System Sales Value by Type (%), 2025 vs 2032

Figure 49. China Microphysiological System Sales Value by Application (%), 2025 vs 2032

Figure 50. Japan Microphysiological System Sales Value (US$ Million), 2021–2032

Figure 51. Japan Microphysiological System Sales Value by Type (%), 2025 vs 2032

Figure 52. Japan Microphysiological System Sales Value by Application (%), 2025 vs 2032

Figure 53. South Korea Microphysiological System Sales Value (US$ Million), 2021–2032

Figure 54. South Korea Microphysiological System Sales Value by Type (%), 2025 vs 2032

Figure 55. South Korea Microphysiological System Sales Value by Application (%), 2025 vs 2032

Figure 56. Southeast Asia Microphysiological System Sales Value (US$ Million), 2021–2032

Figure 57. Southeast Asia Microphysiological System Sales Value by Type (%), 2025 vs 2032

Figure 58. Southeast Asia Microphysiological System Sales Value by Application (%), 2025 vs 2032

Figure 59. India Microphysiological System Sales Value (US$ Million), 2021–2032

Figure 60. India Microphysiological System Sales Value by Type (%), 2025 vs 2032

Figure 61. India Microphysiological System Sales Value by Application (%), 2025 vs 2032

Figure 62. Microphysiological System Value Chain

Figure 63. Microphysiological System Cost Structure

Figure 64. Channels of Distribution (Direct Sales, and Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Microphysiological System in 2026? zhanKai

The global market size of Microphysiological System in 2026 was 178 Million USD.

What is the annual compound growth rate of the global Microphysiological System market size from 2026 to 2032? shouQi

Which region is expected to have the highest market share? shouQi

What was the global market size of Microphysiological System in 2032? shouQi

Which companies rank high in the global Microphysiological System market? shouQi

Related Reports

Global Microphysiological System Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Microphysiological System market is projected to grow from US$ 150 million in 2025 to US$ 438 million by 2032, at a CAGR of 16.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-08-27
Pages: 187
USD 4900.00
(Single User License)
Global Microphysiological System Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Microphysiological System market size was US$ 150 million in 2025 and is forecast to reach a readjusted size of US$ 438 million by 2032 with a CAGR of 16.2% during the forecast period 2026-2032.
Published Date: 2026-08-27
Pages: 168
USD 4250.00
(Single User License)
Global Microphysiological System Market Research Report 2026
The global Microphysiological System market was valued at US$ 150 million in 2025 and is anticipated to reach US$ 438 million by 2032, at a CAGR of 16.2% from 2026 to 2032.
Published Date: 2026-08-27
Pages: 168
USD 2900.00
(Single User License)
Microphysiological System- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Microphysiological System was estimated to be worth US$ 148 million in 2024 and is forecast to a readjusted size of US$ 1134 million by 2031 with a CAGR of 34.3% during the forecast period 2025-2031.
Published Date: 2025-10-14
Pages: 222
USD 3950.00
(Single User License)
Microphysiological System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Microphysiological System was estimated to be worth US$ 126 million in 2024 and is forecast to a readjusted size of US$ 370 million by 2031 with a CAGR of 16.2% during the forecast period 2025-2031.
Published Date: 2025-10-13
Pages: 180
USD 3950.00
(Single User License)
Global Microphysiological System Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Microphysiological System market size was US$ 126 million in 2024 and is forecast to a readjusted size of US$ 370 million by 2031 with a CAGR of 16.2% during the forecast period 2025-2031.
Published Date: 2025-10-13
Pages: 121
USD 4250.00
(Single User License)
Global Microphysiological System Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Microphysiological System market is projected to grow from US$ 126 million in 2024 to US$ 370 million by 2031, at a CAGR of 16.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-13
Pages: 177
USD 4900.00
(Single User License)
Global Microphysiological System Market Research Report 2025
The global market for Microphysiological System was valued at US$ 126 million in the year 2024 and is projected to reach a revised size of US$ 370 million by 2031, growing at a CAGR of 16.2% during the forecast period.
Published Date: 2025-10-13
Pages: 119
USD 2900.00
(Single User License)
Global and China Microphysiological System Market Report & Forecast 2024-2030
Microphysiological Systems (MPS) are in vitro models composed of cells, tissue explants, or stem-cell derived 'organoid' formations of human or animal origin. These models provide translational biochemical, electrical, and/or physiomechanical responses to represent organ and tissue function, with great potential to replace some animals used in research. According to the U.S. Food and Drug Administration (FDA), MPS model "functional features of a specific tissue or organ of human or animal origin by exposing cells to a microenvironment that mimics the physiological aspects important for their function or pathophysiological condition." These systems are being developed to better mimic some aspects of specific organ systems or combinations of organ systems to improve upon standard two-dimensional (2D) cell systems, with the goal of eventually replacing animal models being used for hazard identification, risk assessment, and disease modeling, among other uses.
Published Date: 2024-09-04
Pages: 165
USD 4350.00
(Single User License)
Microphysiological System- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Microphysiological Systems (MPS) are in vitro models composed of cells, tissue explants, or stem-cell derived 'organoid' formations of human or animal origin. These models provide translational biochemical, electrical, and/or physiomechanical responses to represent organ and tissue function, with great potential to replace some animals used in research. According to the U.S. Food and Drug Administration (FDA), MPS model "functional features of a specific tissue or organ of human or animal origin by exposing cells to a microenvironment that mimics the physiological aspects important for their function or pathophysiological condition." These systems are being developed to better mimic some aspects of specific organ systems or combinations of organ systems to improve upon standard two-dimensional (2D) cell systems, with the goal of eventually replacing animal models being used for hazard identification, risk assessment, and disease modeling, among other uses.
Published Date: 2024-09-04
Pages: 168
USD 3950.00
(Single User License)

Global Microphysiological System Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Microphysiological System market is projected to grow from US$ 150 million in 2025 to US$ 438 million by 2032, at a CAGR of 16.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-08-27
Pages: 187
USD 4900.00 (Single User License)
Global Microphysiological System Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Microphysiological System market size was US$ 150 million in 2025 and is forecast to reach a readjusted size of US$ 438 million by 2032 with a CAGR of 16.2% during the forecast period 2026-2032.
Published: 2026-08-27
Pages: 168
USD 4250.00 (Single User License)
Global Microphysiological System Market Research Report 2026
The global Microphysiological System market was valued at US$ 150 million in 2025 and is anticipated to reach US$ 438 million by 2032, at a CAGR of 16.2% from 2026 to 2032.
Published: 2026-08-27
Pages: 168
USD 2900.00 (Single User License)
Microphysiological System- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Microphysiological System was estimated to be worth US$ 148 million in 2024 and is forecast to a readjusted size of US$ 1134 million by 2031 with a CAGR of 34.3% during the forecast period 2025-2031.
Published: 2025-10-14
Pages: 222
USD 3950.00 (Single User License)
Microphysiological System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Microphysiological System was estimated to be worth US$ 126 million in 2024 and is forecast to a readjusted size of US$ 370 million by 2031 with a CAGR of 16.2% during the forecast period 2025-2031.
Published: 2025-10-13
Pages: 180
USD 3950.00 (Single User License)
Global Microphysiological System Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Microphysiological System market size was US$ 126 million in 2024 and is forecast to a readjusted size of US$ 370 million by 2031 with a CAGR of 16.2% during the forecast period 2025-2031.
Published: 2025-10-13
Pages: 121
USD 4250.00 (Single User License)
Global Microphysiological System Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Microphysiological System market is projected to grow from US$ 126 million in 2024 to US$ 370 million by 2031, at a CAGR of 16.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-13
Pages: 177
USD 4900.00 (Single User License)
Global Microphysiological System Market Research Report 2025
The global market for Microphysiological System was valued at US$ 126 million in the year 2024 and is projected to reach a revised size of US$ 370 million by 2031, growing at a CAGR of 16.2% during the forecast period.
Published: 2025-10-13
Pages: 119
USD 2900.00 (Single User License)
Global and China Microphysiological System Market Report & Forecast 2024-2030
Microphysiological Systems (MPS) are in vitro models composed of cells, tissue explants, or stem-cell derived 'organoid' formations of human or animal origin. These models provide translational biochemical, electrical, and/or physiomechanical responses to represent organ and tissue function, with great potential to replace some animals used in research. According to the U.S. Food and Drug Administration (FDA), MPS model "functional features of a specific tissue or organ of human or animal origin by exposing cells to a microenvironment that mimics the physiological aspects important for their function or pathophysiological condition." These systems are being developed to better mimic some aspects of specific organ systems or combinations of organ systems to improve upon standard two-dimensional (2D) cell systems, with the goal of eventually replacing animal models being used for hazard identification, risk assessment, and disease modeling, among other uses.
Published: 2024-09-04
Pages: 165
USD 4350.00 (Single User License)
Microphysiological System- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Microphysiological Systems (MPS) are in vitro models composed of cells, tissue explants, or stem-cell derived 'organoid' formations of human or animal origin. These models provide translational biochemical, electrical, and/or physiomechanical responses to represent organ and tissue function, with great potential to replace some animals used in research. According to the U.S. Food and Drug Administration (FDA), MPS model "functional features of a specific tissue or organ of human or animal origin by exposing cells to a microenvironment that mimics the physiological aspects important for their function or pathophysiological condition." These systems are being developed to better mimic some aspects of specific organ systems or combinations of organ systems to improve upon standard two-dimensional (2D) cell systems, with the goal of eventually replacing animal models being used for hazard identification, risk assessment, and disease modeling, among other uses.
Published: 2024-09-04
Pages: 168
USD 3950.00 (Single User License)